Cutivate Adverse Reactions

Adverse events are listed as follows by organ class and frequency. Frequencies are defined as follows: very common (≥1/10), common (≥1/100 and <1/10), uncommon (≥1/1000 and <1/100), rare (≥1/10,000 and <1/1000) and very rare (<1/10,000) including isolated reports.
Infections and infestations: Very rare: Opportunistic infection.
Immune system disorders: Very rare: Hypersensitivity.
Endocrine disorders: Very rare: Hypothalamic-pituitary-adrenal (HPA) axis suppression: Increased weight / obesity; Delayed weight gain/growth retardation in children; Cushingoid features (e.g. moon face, central obesity); Decreased endogenous cortisol levels; Hyperglycaemia/glucosuria; Hypertension; Osteoporosis; Cataract; Glaucoma.
Eye disorders: Not known: Vision, blurred (see Precautions).
Skin and subcutaneous tissue disorders: Common: Pruritus.
Uncommon: Local burning sensation.
Very rare: Skin thinning, atrophy, striae, telangiectasias, pigmentation changes, hypertrichosis, allergic contact dermatitis, exacerbation of underlying symptoms, pustular psoriasis, erythema, rash, urticaria.